Chapter 25 The Burden

Cancer in North America

Lung cancer remains the leading cause of cancer death in North America, despite four decades of declines in smoking prevalence.

Cancer is the leading cause of premature death in North America. An estimated 2.1 million new cancer cases and 701,000 cancer deaths occur in North America each year. The region contributes almost twice the proportion of cases compared to deaths globally (13% versus 7%) in large part because of high access to early detection and treatment.

Cancer patterns are similar in the United States and Canada, reflecting a shared prevalence of risk factors. Incidence is low for infection-related cancers, almost half of which are attributable to human papillomavirus, and high for cancers associated with unhealthy behavioral factors like smoking, excess body fatness, and sedentary lifestyle. The most common cancers are breast, lung, prostate, and colorectal (Figure 25.1).

Young-onset colorectal cancer is on the rise, now the leading cause of cancer death among young men and the second leading cause among young women in the United States.

Figure 25.1

Estimated number of cancer cases and deaths (excluding non-melanoma skin cancer) by cancer type in North America, 2022

Breast
Lung
Prostate
Colorectum
Melanoma of skin
Bladder
Pancreas
Liver
Other specified cancers

“Treatment without prevention is simply unsustainable.”

—Bill Gates Co-founder, Microsoft and the Gates Foundation

Despite decades of decline, lung cancer remains the leading cause of cancer death, accounting for more deaths in 2022 than colorectal (second) and pancreatic (third) cancers combined (Figure 25.1). Women in North America have the highest lung cancer incidence in 20 United Nations regions, in part because of slower cessation and smoking upticks in those born in the middle of last century, whereas men rank seventh. Consequently, lung cancer incidence in women is higher than in men among people ages 35-64 years in the United States. Rates also vary dramatically by state, province, and territory (Map 25.1).

Incidence for many other cancers is increasing during the most recent period, including prostate and breast, the two most common cancers (Figure 25.2).

Incidence rates are increasing for several cancers, including prostate and breast, the two most common cancers.

Figure 25.2

​Trends in breast and prostate cancer incidence in North America, age-standardized rates (world) per 100,000, 2000-2021

The rise in breast cancer incidence is partly attributed to increased body weight, which also may have contributed to increasing trends in early-onset colorectal cancer (see Colorectal Cancer), pancreatic cancer, kidney cancer, and uterine corpus cancer in the region (Figure 25.3).

Uterine corpus cancer, closely linked to excess body fatness, is rising rapidly in both the United States and Canada.

Figure 25.3

​Trends in uterine corpus cancer incidence (1978-2017) and mortality (1979-2020) in North America​, age-standardized rates (world) per 100,000

Incidence
Mortality

Sources

Text

  • Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. May-Jun 2024;74(3):229-263. doi:10.3322/caac.21834
  • de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. Feb 2020;8(2):e180-e190. doi:10.1016/s2214-109x(19)30488-7
  • CiNA Explorer: An interactive tool for quick access to key NAACCR cancer statistics based on the Cancer in North America (CiNA) dataset from the North American Association of Central Cancer Registries. https://apps.naaccr.org/explorer. Springfield, IL: North American Association of Central Cancer Registries, Inc. , 2023.
  • Jemal A, Schafer EJ, Sung H, et al. The Burden of Lung Cancer in Women Compared With Men in the US. JAMA Oncol. Dec 1 2023;9(12):1727-1728. doi:10.1001/jamaoncol.2023.4415
  • SEER*Stat Database: NAACCR Incidence Data - CiNA Research Data, 2000-2020, Public Use (20 Age Groups); includes data from CDC’s National Program of Cancer Registries, CCCR’s Provincial and Territorial Registries, and the NCI’s Surveillance, Epidemiology and End Results Registries, North American Association of Central Cancer Registries, submitted December 2022., 2023.
  • Pfeiffer RM, Webb-Vargas Y, Wheeler W, Gail MH. Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions. Cancer Epidemiol Biomarkers Prev. Oct 2018;27(10):1214-1222. doi:10.1158/1055-9965.Epi-18-0098

Maps

  • Map 25.1: CiNA Explorer: An interactive tool for quick access to key NAACCR cancer statistics based on the Cancer in North America (CiNA) dataset from the North American Association of Central Cancer Registries. Available from https://apps.naaccr.org/explorer. Springfield, IL: North American Association of Central Cancer Registries, Inc., 2023.

Figures

  • Figure 25.1: Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3): 229-263.
  • Figure 25.2: CiNA Explorer: An interactive tool for quick access to key NAACCR cancer statistics based on the Cancer in North America (CiNA) dataset from the North American Association of Central Cancer Registries. Available from https://apps.naaccr.org/explorer. Springfield, IL: North American Association of Central Cancer Registries, Inc., 2023.
  • Figure 25.3: Ervik M, Lam F, Laversanne M, Colombet M, Ferlay J, Miranda-Filho A, Bray F (2024). Global Cancer Observatory: Cancer Over Time. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/overtime